The NATO Advanced Study Institute of "Molecular and Applied Aspects of Oxida tive Drug Metabolizing Enzymes" was held in Tekirova, Antalya, Turkey, from August 31 to September 11, 1997. This Institute was the third of a series of the NATO ASIs on a similar topic relating to the enzymes of oxidative metabolism of xenobiotics. The first NATO ASI in this series, entitled "Molecular Aspects of Monooxygenases and Bioactiva tion of Toxic Compounds" (NATO ASI Series A: Life Sciences, Vol. 202), was held in
The NATO Advanced Study Institute of "Molecular and Applied Aspects of Oxida tive Drug Metabolizing Enzymes" was held in Tekirova, Antalya, Turkey, from August 31 to September 11, 1997. This Institute was the third of a series of the NATO ASIs on a similar topic relating to the enzymes of oxidative metabolism of xenobiotics. The first NATO ASI in this series, entitled "Molecular Aspects of Monooxygenases and Bioactiva tion of Toxic Compounds" (NATO ASI Series A: Life Sciences, Vol. 202), was held inHinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
The Fate of Xenobiotics in the Body; Enzymes of Metabolism; J.B. Schenkman. Protein-Protein Interactions in the P450 Monooxygenase System; J.B. Schenkman, et al. Structures of Mitochondrial P450 System Proteins; I. Hanukoglu. Biochemical Aspects of Flavin-Containing Monooxygenases (FMOs); E. Hodgson, et al. Expression and Regulation of Flavin-Containing Monooxygenases; R.M. Philpot, et al. Correlations between in Vivo and in Vitro Studies in Human Drug Metabolism; M. Eichelbaum. Pharmacogenetics: Polymorphisms in Xenobiotic Metabolism; F.J. Gonzalez. Clinical Aspects of Polymorphic Drug Metabolism in Humans; M. Eichelbaum. Genetic Polymorphisms of Cytochromes P450 1A1 and 2E1 and Glutathione S-Transferase M1 and Cancer Susceptibility in the Human; M. Watanabe. Cytochrome P450 Isoforms: Insecticide Metabolism in Insects and Mammals and Role in Insecticide Resistance; E. Hodgson, et al. Inhibitors of CYP51 as Antifungal Agents and Resistance to Azole Antifungals; S.L. Kelly, et al.
The Fate of Xenobiotics in the Body; Enzymes of Metabolism; J.B. Schenkman. Protein-Protein Interactions in the P450 Monooxygenase System; J.B. Schenkman, et al. Structures of Mitochondrial P450 System Proteins; I. Hanukoglu. Biochemical Aspects of Flavin-Containing Monooxygenases (FMOs); E. Hodgson, et al. Expression and Regulation of Flavin-Containing Monooxygenases; R.M. Philpot, et al. Correlations between in Vivo and in Vitro Studies in Human Drug Metabolism; M. Eichelbaum. Pharmacogenetics: Polymorphisms in Xenobiotic Metabolism; F.J. Gonzalez. Clinical Aspects of Polymorphic Drug Metabolism in Humans; M. Eichelbaum. Genetic Polymorphisms of Cytochromes P450 1A1 and 2E1 and Glutathione S-Transferase M1 and Cancer Susceptibility in the Human; M. Watanabe. Cytochrome P450 Isoforms: Insecticide Metabolism in Insects and Mammals and Role in Insecticide Resistance; E. Hodgson, et al. Inhibitors of CYP51 as Antifungal Agents and Resistance to Azole Antifungals; S.L. Kelly, et al.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826